Myriad Genetics acquires Counsyl for $375m

Myriad Genetics acquires Counsyl for $375m

Source: 
GoinPharma
snippet: 

Myriad Genetics some hours ago announced that it has acquired for $375m Counsyl, a company that develops and markets non-invasive screening systems to determine whether fetuses risk to develop  genetic diseases.